{"id":"https://openalex.org/W1499405019","doi":null,"title":"Epigenetic regulation of the TRAIL/Apo2L apoptotic pathway by histone deacetylase inhibitors: an attractive approach to bypass melanoma immunotherapy resistance.","display_name":"Epigenetic regulation of the TRAIL/Apo2L apoptotic pathway by histone deacetylase inhibitors: an attractive approach to bypass melanoma immunotherapy resistance.","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W1499405019","mag":"1499405019","pmid":"https://pubmed.ncbi.nlm.nih.gov/23885325","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3714203"},"language":"en","primary_location":{"id":"pmh:oai:europepmc.org:2713987","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3714203","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3714203","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010565662","display_name":"Ali R. Jazirehi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4390039293","display_name":"UCLA Jonsson Comprehensive Cancer Center","ror":"https://ror.org/0599cs764","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I4390039293"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ali R Jazirehi","raw_affiliation_strings":["Department of Surgery, Division of Surgical Oncology, and the Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, University of California at Los Angeles Los Angeles, California 90095"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Division of Surgical Oncology, and the Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, University of California at Los Angeles Los Angeles, California 90095","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I4390039293"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047277937","display_name":"Dylan Arle","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dylan Arle","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4296,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.79992471,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"2","issue":"1","first_page":"55","last_page":"74"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.6079000234603882,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.6079000234603882,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.3792000114917755,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trail","display_name":"TRAIL","score":0.8009999990463257},{"id":"https://openalex.org/keywords/apo2l","display_name":"Apo2L","score":0.8840000033378601},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.9940000176429749},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.921999990940094},{"id":"https://openalex.org/keywords/immunotherapy-resistance","display_name":"immunotherapy resistance","score":0.9020000100135803},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.777999997138977},{"id":"https://openalex.org/keywords/trail-receptors","display_name":"TRAIL receptors","score":0.8109999895095825},{"id":"https://openalex.org/keywords/dr4","display_name":"DR4","score":0.6050000190734863},{"id":"https://openalex.org/keywords/dr5","display_name":"DR5","score":0.996999979019165},{"id":"https://openalex.org/keywords/flip","display_name":"c-FLIP","score":0.7360000014305115},{"id":"https://openalex.org/keywords/caspase-8","display_name":"caspase-8","score":0.9390000104904175},{"id":"https://openalex.org/keywords/vorinostat","display_name":"vorinostat","score":0.8980000019073486},{"id":"https://openalex.org/keywords/agonistic-monoclonal-antibody","display_name":"agonistic monoclonal antibody","score":0.8629999756813049},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.718999981880188},{"id":"https://openalex.org/keywords/epigenetic-regulation","display_name":"epigenetic regulation","score":0.7940000295639038}],"concepts":[{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.701765775680542},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6253085136413574},{"id":"https://openalex.org/C2776202225","wikidata":"https://www.wikidata.org/wiki/Q3569101","display_name":"Histone deacetylase inhibitor","level":5,"score":0.5884369611740112},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5840123891830444},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.4976828396320343},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4728658199310303},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4723052978515625},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4694732427597046},{"id":"https://openalex.org/C119056186","wikidata":"https://www.wikidata.org/wiki/Q1431332","display_name":"Gene silencing","level":3,"score":0.43041759729385376},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.42932212352752686},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.42921513319015503},{"id":"https://openalex.org/C33195913","wikidata":"https://www.wikidata.org/wiki/Q20970121","display_name":"XIAP","level":5,"score":0.41880834102630615},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.39663130044937134},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38496994972229004},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.376385360956192},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.2565997838973999},{"id":"https://openalex.org/C98424977","wikidata":"https://www.wikidata.org/wiki/Q25805","display_name":"Caspase","level":4,"score":0.23706656694412231},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.18346217274665833},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.10805889964103699},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06527838110923767},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"pmh:oai:europepmc.org:2713987","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3714203","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3714203","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3714203","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Am J Clin Exp Immunol","raw_type":"Text"},{"id":"pmid:23885325","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23885325","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of clinical and experimental immunology","raw_type":"Journal Article"},{"id":"mag:1499405019","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23885325","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:europepmc.org:2713987","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3714203","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G318260890","display_name":"Resistance to apoptosis in clinical melanoma gene therapy","funder_award_id":"R21CA149938","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W67197765","https://openalex.org/W68167480","https://openalex.org/W1755076441","https://openalex.org/W1838284135","https://openalex.org/W2119930182","https://openalex.org/W2418246656"],"related_works":["https://openalex.org/W2166493740","https://openalex.org/W1995443667","https://openalex.org/W1963998118","https://openalex.org/W1978016743","https://openalex.org/W2944070717","https://openalex.org/W2028839489","https://openalex.org/W2168455351","https://openalex.org/W746922644","https://openalex.org/W1593453792","https://openalex.org/W2016770760"],"abstract_inverted_index":{"TNF-related":[0],"apoptosis-inducing":[1],"ligand":[2],"(TRAIL/Apo2L)":[3],"is":[4,168],"a":[5,93],"major":[6],"cytotoxic":[7,11],"mechanism":[8],"employed":[9],"by":[10,269],"T":[12],"lymphocytes":[13],"(CTL)":[14],"and":[15,44,52,85,121,189,254,266],"natural":[16],"killer":[17],"(NK)":[18],"cells":[19,99],"to":[20,79,105,127,131,158,237,241,276],"eradicate":[21],"malignant":[22],"cells.":[23,91],"TRAIL/Apo2L":[24,56,63,253],"interacts":[25],"with":[26,228,261],"its":[27,255],"cognate":[28],"receptors":[29,65,120],"located":[30],"on":[31,249,263],"tumor":[32],"cell":[33],"surface":[34],"namely,":[35],"TRAIL-R1":[36],"(DR4),":[37],"TRAIL-R2":[38],"(DR5),":[39],"TRAIL-R3":[40],"(DcR1),":[41],"TRAIL-R4":[42],"(DcR2)":[43],"osteoprotegerin":[45],"(OPG).":[46],"The":[47,140],"exact":[48],"function":[49],"of":[50,83,87,112,115,118,125,134,142,148,165,186,193,232,252],"DcR1":[51],"DcR2":[53],"remains":[54],"elusive.":[55],"or":[57,102],"agonistic":[58,256],"monoclonal":[59],"antibodies":[60],"directed":[61],"against":[62],"death-inducing":[64],"(DR4,":[66],"DR5)":[67],"have":[68,213,235],"become":[69],"an":[70,122],"attractive":[71],"immunological":[72],"therapeutic":[73],"tools":[74],"in":[75,151,202,226,258],"clinical":[76],"oncology":[77],"due":[78,130],"their":[80],"selective":[81],"killing":[82],"tumors":[84],"lack":[86],"affinity":[88],"towards":[89],"healthy":[90],"Though":[92],"potent":[94],"anti-cancer":[95],"modality,":[96],"some":[97,203],"cancer":[98,218],"exhibit":[100],"inherent":[101],"acquired":[103],"resistance":[104,108,143,240],"TRAIL/Apo2L.":[106],"Postulated":[107],"mechanisms":[109],"include":[110],"up-regulation":[111],"c-FLIP,":[113],"down-regulation":[114],"caspase-8,":[116],"down-regulation/shedding":[117],"death":[119],"imbalanced":[123],"ratio":[124],"pro-":[126],"anti-apoptotic":[128],"genes":[129,188],"aberrant":[132],"activity":[133],"cellular":[135,265],"survival":[136],"signal":[137],"transduction":[138],"pathways.":[139],"development":[141],"has":[144],"spurred":[145],"the":[146,191,250],"use":[147],"combination":[149],"therapy,":[150],"particular":[152],"using":[153],"small":[154],"molecule":[155],"sensitizing":[156],"agents,":[157],"restore":[159],"apoptosis":[160],"sensitivity.":[161],"A":[162],"novel":[163],"category":[164],"such":[166,207],"compounds":[167],"histone":[169,181],"deacetylase":[170],"inhibitors":[171],"(HDACi),":[172],"which":[173,270],"block":[174],"HDACs":[175],"from":[176,180],"removing":[177],"acetyl":[178],"groups":[179],"tails":[182],"thereby":[183],"preventing":[184],"silencing":[185],"pro-apoptotic":[187],"regulating":[190],"expression":[192],"non-histone":[194],"proteins":[195],"(i.e.,":[196],"apoptosis-associated":[197],"genes),":[198],"are":[199],"effective":[200],"agents":[201],"malignancies.":[204],"Some":[205],"HDACi,":[206],"as":[208],"Suberoylanilide":[209],"Hydroxamic":[210],"Acid":[211],"(SAHA),":[212],"received":[214],"FDA":[215],"approval":[216],"for":[217],"treatment.":[219],"In":[220],"various":[221],"melanoma":[222,259,275],"preclinical":[223],"models,":[224],"HDACi":[225,271],"conjunction":[227],"TRAIL/Apo2L,":[229],"via":[230],"modulation":[231],"apoptotic":[233],"machinery,":[234],"proven":[236],"overcome":[238],"acquired/inherent":[239],"either":[242],"agent.":[243],"Here,":[244],"we":[245],"discuss":[246],"recent":[247],"findings":[248],"role":[251],"mAbs":[257],"immunotherapy":[260],"discussions":[262],"potential":[264],"molecular":[267],"events":[268],"can":[272],"sensitize":[273],"metastatic":[274],"TRAIL/Apo2L-mediated":[277],"immune-therapy,":[278],"thereby,":[279],"overcoming":[280],"resistance.":[281]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2016-06-24T00:00:00"}